AMRX Cost of Revenue
Amneal Pharmaceuticals Inc Class A · Cost of Revenue
AMRX Cost of Revenue
Latest reported$1.89Bperiod ending
AMRX Cost of Revenue ($335.99M → $1.89B)
Annual cost of revenue
High-resolution chart · PNG
AMRX cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 1,882,668,000 | |
| 1,773,519,000 | |
| 1,529,738,000 | |
| 1,420,843,000 | |
| 1,324,696,000 | |
| 1,364,130,000 | |
| 1,273,376,000 | |
| 946,588,000 | |
| 507,476,000 | |
| 420,770,000 | |
| 367,054,000 | |
| 335,989,000 |